University of Minnesota. Driven to Discover.
The vaccine "has the potential to save tens of thousands of children's lives."
A total of 62.4% of patients taking tafenoquine were free of P vivax after 6 months.
The outbreak has reached 422 cases, and 74 suspected Ebola infections are under investigation.
Alongside the finding that progress has stalled in hard-hit countries, the WHO and partners launch a new response strategy.
In addition to circulating in blood, Plasmodium vivax is now known to accumulate in bone marrow.
On World Malaria Day, global health leaders aired concerns about stalled progress in some regions and recommitted to the battle against the disease.
Researchers described tactics and tools for use in conflict and humanitarian zones and showed threats from cominated blood bank supplies.
Strains with key drug-resistance genes grew from 16% of samples in 2008 to 68% in 2013.
Recent gains in preventing the disease in pregnancy may be lost as resistance to prophylactic treatment rises.
Researchers identify more than 80 genes that contribute to resistance.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.